Skip to main content
ACBT logo

ACBT — Investor Relations & Filings

Ticker · 4148 ISIN · KYG0232P1072 TW Manufacturing
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-03-08 Director's Dealing
Country TW Taiwan
Listing TW 4148

About ACBT

www.allcosmos.com

All Cosmos Bio-Tech Holding Corporation specializes in the application of microbiology to develop and manufacture high-performance bio-chemical fertilizers. Its core products utilize a proprietary formulation combining organic matter, beneficial microorganisms, and chemical elements to enhance soil health and productivity. The company also engages in waste reutilization, applying biotechnological processes to convert organic waste into sustainable resources, and conducts research and development of microbial strains for health care and pharmaceutical applications. By leveraging advanced microbial R&D, the organization provides solutions designed to reduce reliance on traditional chemical inputs and promote circular economy principles. Its activities focus on the synthesis of biological and chemical technologies to provide sustainable alternatives for soil management and resource recovery.

Recent filings

Filing Released Lang Actions
110年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, managers, and major shareholders, with specific numbers of shares held, pledged shares, and related information. It includes data on shareholdings of various internal persons and their relationships, but does not contain financial statements, earnings data, or management discussion. The document is not a report or announcement of financial results, nor is it a regulatory filing about a report publication or certification. It is a disclosure of insider shareholdings and pledges, which corresponds to a Director's Dealing report, as it details personal share transactions or holdings by company directors and executives. The document length is 3081 characters, which is relatively short but contains substantive insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS).
2021-03-08 Chinese
110年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and stock ownership information of company insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholdings and changes thereof. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is not a report itself but a disclosure of insider share transactions or holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider holdings, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2021-03-08 Chinese
110年2月背書保證與資金貸與
Capital/Financing Update Classification · 95% confidence The document is a financial disclosure from a listed company, 全宇生技-KY, providing detailed figures on fund loans, endorsements, and guarantees for the current and previous months. It includes specific monetary amounts and limits, indicating a regulatory compliance or financial status update. The document length is short (633 characters) and it primarily contains tabulated financial data related to capital and guarantees rather than a full financial report or management discussion. There is no indication of an annual or quarterly report, audit report, or earnings release. The content fits best with a Capital/Financing Update as it relates to the company's financing activities and guarantees.
2021-03-08 Chinese
110年2月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary showing monthly and cumulative revenue figures for a company (全宇生技-KY) in New Taiwan Dollars and functional currency (Malaysian Ringgit). It includes percentage changes compared to the previous year and exchange rates. The document length is very short (656 characters) and contains only summarized revenue data without detailed financial statements or analysis. There is no indication that this is a full annual or interim report, nor is it a regulatory filing or announcement of a report. Given the concise nature and focus on key financial facts, this fits the definition of a Fund Information / Factsheet (FS), which is a brief summary of key company facts and financials.
2021-03-08 Chinese
110年1月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief financial summary showing monthly and cumulative revenue figures for a company (全宇生技-KY) in New Taiwan Dollars and functional currency (Malaysian Ringgit). It includes percentage changes compared to the previous year and exchange rates. The document length is very short (651 characters) and contains no detailed financial statements or comprehensive analysis. It appears to be a revenue summary or sales report rather than a full financial report. Given the short length and nature of the content, it does not qualify as an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more consistent with a Fund Information / Factsheet (FS) which typically provides brief summaries of key financial data. Therefore, the best classification is FS with high confidence.
2021-02-05 Chinese
110年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 全宇生技-KY, providing data on loan balances and guarantee information for the current and previous months. It contains tabulated financial figures but is very short (633 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of specific financial data rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or other detailed filings. Given the nature and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-02-05 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.